Related Experiment Videos
How effective is digitalis in the treatment of congestive heart failure?
1Division of Cardiovascular Medicine, University of Massachusetts Medical Center, Worcester 01655.
Insights
Digitalis glycosides offer a moderate positive inotropic effect, enhancing ventricular performance, especially in failing hearts. Clinical use in chronic heart failure patients in sinus rhythm shows benefits, with safe administration in coronary artery disease.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Digitalis glycosides are commonly used for heart conditions.
- Understanding their precise effects on myocardial function is crucial.
Purpose of the Study:
- To evaluate the impact of digitalis glycosides on ventricular performance.
- To assess the clinical efficacy in chronic heart failure (CHF).
Main Methods:
- Review of existing evidence on digitalis glycosides.
- Analysis of effects on failing and nonfailing myocardium.
- Examination of clinical studies in CHF patients.
Main Results:
- Digitalis glycosides provide a sustained, moderate positive inotropic effect.
- This effect is more pronounced in failing myocardium.
- Clinical studies indicate a moderate benefit in CHF patients with sinus rhythm.
Conclusions:
- Digitalis glycosides improve ventricular performance.
- They are beneficial in select chronic heart failure patients.
- Safe use is possible in coronary artery disease (CAD) with awareness of sensitivity factors.
Abstract:
The evidence suggests that digitalis glycosides do indeed improve ventricular performance through a sustained but moderate positive inotropic effect. This effect is more marked in failing than in nonfailing myocardium. The clinical studies suggest a moderate salutary effect in patients with chronic CHF who are in sinus rhythm. The drug can be given safely to patients with CAD and in combination with other medications when the physician is aware of those factors leading to increased sensitivity to digitalis.